tiprankstipranks
Cellectar Biosciences (CLRB)
NASDAQ:CLRB
US Market

Cellectar Biosciences (CLRB) Income Statement

Compare
1,318 Followers

Cellectar Biosciences Income Statement

Last quarter (Q3 2024), Cellectar Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Cellectar Biosciences's net income was $-14.66M. See Cellectar Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -192.38K$ -238.87K$ -227.64K$ -207.93K$ -189.36K
Operating Expenses
$ 38.96M$ 28.81M$ 24.13M$ 15.29M$ 14.18M
Depreciation and Amortization
$ 192.38K$ 238.87K$ 227.64K$ 207.93K$ 189.36K
EBITDA
$ -38.77M$ -28.67M$ -23.98M$ -15.15M$ -13.90M
Operating Income
$ -38.96M$ -28.81M$ -24.13M$ -15.29M$ -14.18M
Other Income/Expenses
$ 917.15K$ 152.52K$ 8.92K$ 196.18K$ 85.71K
Pretax Income
$ -38.04M$ -28.66M$ -24.12M$ -15.09M$ -14.09M
Net Income
$ -37.98M$ -28.60M$ -23.97M$ -14.76M$ -13.87M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.11$ -4.05$ -4.32$ -7.45$ -18.08
Diluted EPS
$ -3.11$ -4.05$ -4.32$ -7.45$ -18.08
Weighted Average Shares Outstanding
12.22M 7.06M 5.55M 1.98M 767.51K
Weighted Average Shares Outstanding (Diluted)
12.22M 7.06M 5.55M 1.98M 767.51K
Currency in USD

Cellectar Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis